新興のインスリンドラッグデリバリーデバイスの世界市場は、2023年の558億ドルから、2028年末には889億ドルに達すると予測され、2023年から2028年までのCAGRは9.8%と推定されます。
目次
Chapter- 1: Introduction
Overview
Study Goals and Objectives
Reasons for Doing the Study
What's New in this Report?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Segmentation Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Summary
Developments and Trends
Chapter- 3: Market Overview
Introduction
What is Diabetes?
Types of Diabetes
Epidemiology of Diabetes
Market Dynamics Snapshot
Factors Affecting the Market
Chapter- 4: Global Market for Emerging Insulin Drug and Delivery Technologies, by Type
Overview
Insulin Delivery Pen Devices
External Insulin Pumps
Implantable Insulin Pumps
Smart Pens
Chapter- 5: Global Market for Emerging Insulin Drug Delivery Devices, by Application
Overview
Chapter- 6: Global Market for for Insulin Drug Delivery Devices, by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 7: Regulatory Landscape
Overview
Chapter- 8: Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective
Introduction
Chapter- 9: Emerging Technologies
Introduction
Patient Outcomes Beyond Glucose Control
Chapter- 10: Patent Analysis
Overview
Chapter- 11: M&A and Venture Funding Outlook
M&A Analysis
Chapter- 12: Competitive Landscape
Overview
Chapter- 13: Company Profiles
ASTRAZENECA
B. BRAUN SE
BD
CARDINAL HEALTH
DEBIOTECH SA
DIABELOOP SA
EMPERRA GMBH E-HEALTH TECHNOLOGIES
EMBECTA CORP.
F. HOFFMANN-LA ROCHE LTD.
INSULET CORP.
JOHNSON & JOHNSON SERVICES INC.
LIFESCAN IP HOLDINGS LLC.
LILLY
MEDTRONIC
NOVO NORDISK A/S
NUGEN MEDICAL DEVICES
OWEN MUMFORD LTD.
SANOFI
SOOIL DEVELOPMENTS CO. LTD.
TANDEM DIABETES CARE INC.
TERUMO CORP.
YPSOMED AG
Chapter- 14: Appendix
Government Regulatory Agencies and Professional Organizations
